Category Archives: Stem Cell Research

Home Mail News Sports Finance Weather Games Groups Answers Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Mobile Yahoo! News Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo! Home Video Photos GMA Year in Review Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Sideshow Katie's Take Power Players This Could Be Big Newsmakers Trending Now The Upbeat Who Knew? Nightline Fix … Continue reading →

Golden, Colorado - (ACCESSWIRE - September 10, 2013) - Vitro Diagnostics, Inc. (VODG), dba Vitro Biopharma, announced expansion of its current product lines and product development in additional market segments including drug discovery & development together with select opportunities within regenerative medicine market sectors. Vitro's present products target markets within stem cell and cancer research. We provide basic research tools including cell lines, cell culture media and assays of cellular function. We have recently added cancer-associated fibroblast cell lines and novel cell culture media formulations broadening our product offerings for research. Cancer-associated fibroblasts (CAFs) are non-tumor cells within cancerous tumors that promote tumor growth and metastasis. Also, new evidence, including research using Vitro Biopharma's cell lines, suggest that CAFs mediate immunoprotection of tumor cells and are thus new therapeutic targets for aggressive forms of cancer including pancreatic cancer. We have recently added two new CAF cell lines to our catalog that are derived from ovarian and endometrial cancers. Our specialized culture media for primary cell growth compliments our new products by allowing our customers to derive more cells in a shorter time period accelerating the rate of research using our CAFs. A recent publication involving a specific type of cancer-associated … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/82v6t2/cancer_stem_cells) has announced the addition of the "Cancer Stem Cells Drug Pipeline Update 2013" report to their offering. Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today 308 companies plus partners developing 478 cancer stem cells and developmental pathways drugs in 1568 developmental projects in cancer. In addition, there are 6 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 232 drugs. Cancer Stem Cells Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 257 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 250 out of the 253 studied drug targets so far have been recorded with somatic mutations. All drugs targets are further categorized on in the software application by … Continue reading →

TORONTO, ONTARIO--(Marketwired - Sep 6, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(SCTPF), a biopharmaceutical company developing cancer stem cell-related therapeutics, today announced it will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 8-10, 2013, at the Millennium Broadway Hotel in New York City. Dr. Niclas Stiernholm, the CEO of Stem Cell Therapeutics, will provide an overview of the Company's business during the live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference. About Stem Cell Therapeutics: Stem Cell Therapeutics Corp. (SCT) is a biopharmaceutical company dedicated to advancing cancer stem cell discoveries into novel and innovative cancer therapies. Building on over half a century of leading and groundbreaking Canadian stem cell research, the company is supported by established links to a group of Toronto academic research institutes and cancer treatment centers, representing one of the world's most acclaimed cancer research hubs. The Company has two premier preclinical programs, SIRPaFc and a CD200 monoclonal antibody (mAb), which target two key immunoregulatory pathways that tumor cells exploit to evade the … Continue reading →

SEATTLE and SAN JOSE, Calif., Sept. 5, 2013 /PRNewswire/ --NanoString Technologies, Inc. (NSTG), a provider of life science tools for translational research and molecular diagnostic products, and BD Biosciences, a segment of BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, today announced a collaboration agreement for the development of a single cell isolation and analysis workflow. Under the agreement, the companies will jointly develop a workflow using the NanoString nCounter Analysis System (including the nCounter Single Cell Assay) and the BD Flow Cytometry cell sorter product line (emphasizing the new BD FACSJazz Cell Sorting System). The combined workflow will enable single cell gene expression analysis for research applications such as oncology, immunology and stem cell research. Collaboration activities will also include the development of materials documenting the workflow protocol, as well as co-hosting meetings and webinars to educate scientists about the single cell workflow. "Maximizing both the quantity and quality of data that can be extracted from a single cell is critical to the emerging field of single cell biology. The nCounter Analysis System can analyze entire gene pathways and provides a highly precise and reproducible digital output, making it ideally suited to the task," said … Continue reading →

From disease diagnosis, stem cell research, development of vaccines and precision drugs to value-added fish products and aquaculture technology, the potential opportunities for research and investment in life sciences were highlighted at a conference organised by the Kerala State Industrial Development Corporation (KSIDC) here on Tuesday. Inaugurating the event, Chief Minister Oommen Chandy said the Life Sciences Park coming up at Thonnakkal, near here, offered Kerala an opportunity to take an early lead over other States and make up for what it had lost in the information technology sector. He said the State could make use of the expertise and manpower in institutions such as the Regional Cancer Centre, Rajiv Gandhi Centre for Biotechnology, Jawaharlal Nehru Tropical Botanic Garden and Research Institute, and Central Marine Fisheries Research Institute to forge ahead in life sciences. In his keynote address, Minister for Industries P.K. Kunhalikutty said the Life Sciences Park would become operational in two-and-a-half years. KSIDC Managing Director Tom Jose said the park would foster research-oriented studies based on life sciences to ensure better quality of life and living conditions. He stressed the need for better collaboration between industry and academia in the States endeavour to become one of the top … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/sl5qkk/hematopoietic) has announced the addition of the "Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2013" report to their offering. 'Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hematopoietic Stem Cell Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hematopoietic Stem Cell Transplantation. Scope - A snapshot of the global therapeutic scenario for Hematopoietic Stem Cell Transplantation. - A review of the Hematopoietic Stem Cell Transplantation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Hematopoietic Stem Cell Transplantation pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. Continue reading here: Research and Markets: Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2013 … Continue reading →

Dr. Hanna Mikkola, member of the UCLA Eli & Edythe Broad Center for Regenerative Medicine & Stem Cell Research and the Jonsson Comprehensive Center and an associate professor of molecular, cell, and developmental biology in the life sciences has been named the 2013 recipient of the McCulloch and Till Award by the Society for Hematology and Stem Cells, also known as the ISEH. Established in 2004 in honor of Ernest McCulloch and James Till, who are known as the fathers of stem cell science, this award recognizes junior scientists in the field of experimental hematology and stem cells. The award is given annually to one scientist who is nominated and selected as an outstanding early career investigator in the field. Professors McCulloch and Till are widely considered to be the first scientists to show that the bone marrow contains stem cells, a finding that gave rise to the field of bone marrow transplantation. The driving force and long-standing desire behind Mikkolas research is to improve leukemia treatment by understanding the origin of hematopoietic or blood-producing stem cells (HSCs). Mikkola feels she can best contribute to that mission by uncovering the biological mechanisms that control the development of HSCs with the … Continue reading →

TYSABRI and MS - My Journey #53 and wondering about stem cells... I've had Tysabri 53 and I'm feeling good. I'm very interested in Stem Cell research though. Obviously I can't spell either since I typed "cellls" instead of ... By: Sandra Watts … Continue reading →

Featured Article Academic Journal Main Category: Stem Cell Research Also Included In: Neurology / Neuroscience Article Date: 29 Aug 2013 - 2:00 PDT Current ratings for: Scientists successfully grow 'mini-brains' from stem cells 4.67 (3 votes) 3.67 (3 votes) Scientists have successfully grown complex human brain tissue from stem cells using a new 3D culture system, according to a study published in the journal Nature. Researchers from the Institute of Molecular Biotechnology (IMBA) at the Austrian Academy of Sciences (OeAW) say the newly created tissue could be the start of developing model systems for the human brain. The scientists began the research by using established human embryonic stem cell lines and induced pluripotent stem (iPS) cells from mouse embryonic fibroblasts. They identified growth conditions that helped the stem cells differentiate into a variety of brain tissues. The researchers used "media" for neuronal induction and differentiation, which allowed them to avoid "patterning growth factor conditions." They say that these conditions are usually applied to generate particular cell identities from stem cells. Dr. Jrgen Knoblich from the IMBA and lead study author explains the process: "We modified an established approach to generate so-called neuroectoderm, a cell layer from which the nervous system … Continue reading →